Analyst Pre-Market Updates: Intellicell Biosciences, Therapy Cells, Viper Networks, and Mentor Capitol -----
Intellicell Biosciences, Inc. (OTCQB: SVFC) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. The company has amended its by-laws. Read the details and get a full report at the following link: http://bit.ly/AnalystReportsSVFC copy and paste may be required -----
Therapy Cells, Inc. (PINKSHEETS: TCEL) develops and commercializes a technology for tendon repair for the human market. Its technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. Read about how the company is applying this technology at the following link: http://bit.ly/AnalystReportsTCEL copy and paste may be required -----
Viper Networks, Inc. (PINKSHEETS: VPER) provides LED lighting solutions to metropolitan areas, parking lots, and warehousing facilities. It offers LED street lights; parking lot lighting; indoor lighting; and intelligent lighting solutions with camera, sensor, and wireless technologies in a single design. New financing should help the company develop its ventures into LED lighting in places like Sri Lanka and Qatar, as well as the development of grow light systems for the marijuana industry. Get a full report on these developments at the link: http://bit.ly/AnalystReportsVPER copy and paste may be required -----
Mentor Capitol, Inc. (PINKSHEETS: MNTR) by acquisition or investment, seeks to fund a significant portion of the $140 Million that would flow from the exercise of warrants its shareholders already hold into leading cannabis brands. The company has established a cannabis stock index and is laying the ground work for cannabis related organizations. Read about it here, at the following link: http://bit.ly/AnalystReportsMNTR copy and paste may be required
Get our stock alerts ahead of the crowd on your mobile device text keyword “Profits” to 25827 -----
EDITOR NOTES:
1. Information in this release is fact checked and produced on a best efforts basis and reviewed by Marc Bonacci, Chief Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
2. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
3. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at info@stocksimpossible.com.
4. For any urgent concerns or inquiries, please contact us at info@stocksimpossible.com.
5. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to info@stocksimpossible.com for consideration. -----
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared by Small Cap Street, LLC and authored by Marc Bonacci, Chief Financial Analyst. An outsourced research services provider represented by Marc Bonacci, Chief Financial Analyst, has only reviewed the information provided by Small Cap Street, LLC in this article or report. Small Cap Street, LLC is not entitled to veto, interfere or alter the articles, documents or report once reviewed by the outsourced research provider represented by Marc Bonacci, Chief Financial Analyst.
NOT FINANCIAL ADVICE -----
Small Cap Street, LLC makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED -----
Small Cap Street, LLC is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Small Cap Street, LLC whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Street, LLC expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Street, LLC does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE: StocksImpossible.com
SOURCE Small Cap Street, LLC
Intellicell Biosciences, Inc. (OTCQB: SVFC) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. The company has amended its by-laws. Read the details and get a full report at the following link: http://bit.ly/AnalystReportsSVFC copy and paste may be required -----
Therapy Cells, Inc. (PINKSHEETS: TCEL) develops and commercializes a technology for tendon repair for the human market. Its technology is used for tissue transplantation to aid in the repair and regeneration of damaged, diseased, torn, or ruptured musculoskeletal cells and organs in the human, as well as to grow pancreatic cells, for treatment of diabetes, cardiac cells for the treatment of heart disease, and other cell types from various other tissues. Read about how the company is applying this technology at the following link: http://bit.ly/AnalystReportsTCEL copy and paste may be required -----
Viper Networks, Inc. (PINKSHEETS: VPER) provides LED lighting solutions to metropolitan areas, parking lots, and warehousing facilities. It offers LED street lights; parking lot lighting; indoor lighting; and intelligent lighting solutions with camera, sensor, and wireless technologies in a single design. New financing should help the company develop its ventures into LED lighting in places like Sri Lanka and Qatar, as well as the development of grow light systems for the marijuana industry. Get a full report on these developments at the link: http://bit.ly/AnalystReportsVPER copy and paste may be required -----
Mentor Capitol, Inc. (PINKSHEETS: MNTR) by acquisition or investment, seeks to fund a significant portion of the $140 Million that would flow from the exercise of warrants its shareholders already hold into leading cannabis brands. The company has established a cannabis stock index and is laying the ground work for cannabis related organizations. Read about it here, at the following link: http://bit.ly/AnalystReportsMNTR copy and paste may be required
Get our stock alerts ahead of the crowd on your mobile device text keyword “Profits” to 25827 -----
EDITOR NOTES:
1. Information in this release is fact checked and produced on a best efforts basis and reviewed by Marc Bonacci, Chief Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
2. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
3. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at info@stocksimpossible.com.
4. For any urgent concerns or inquiries, please contact us at info@stocksimpossible.com.
5. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to info@stocksimpossible.com for consideration. -----
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared by Small Cap Street, LLC and authored by Marc Bonacci, Chief Financial Analyst. An outsourced research services provider represented by Marc Bonacci, Chief Financial Analyst, has only reviewed the information provided by Small Cap Street, LLC in this article or report. Small Cap Street, LLC is not entitled to veto, interfere or alter the articles, documents or report once reviewed by the outsourced research provider represented by Marc Bonacci, Chief Financial Analyst.
NOT FINANCIAL ADVICE -----
Small Cap Street, LLC makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED -----
Small Cap Street, LLC is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Small Cap Street, LLC whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Street, LLC expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Street, LLC does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE: StocksImpossible.com
SOURCE Small Cap Street, LLC
